Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB-WT) Net Margin (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Net Margin for 2 consecutive years, with 87.4% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 77838.0% to 87.4% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 325.31% through Dec 2025, up 688845.0% year-over-year, with the annual reading at 325.31% for FY2025, 688845.0% up from the prior year.
  • Net Margin for Q4 2025 was 87.4% at Nuvation Bio, up from 425.24% in the prior quarter.
  • The five-year high for Net Margin was 87.4% in Q4 2025, with the low at 32229.41% in Q2 2024.